31798860|t|Metronidazole- and levofloxacin-induced psychotic disorders in chronic kidney patient.
31798860|a|We present a case which reports the occurrence of psychotic disorders after metronidazole and levofloxacin therapy in a chronic kidney patient while being treated for enterocolitis and urinary infection. A 48-year-old female was admitted to a hospital for the placement of a peritoneal dialysis catheter due to indicated peritoneal dialysis. During admission, symptoms of enterocolitis and urinary infection had occurred, so metronidazole and levofloxacin were introduced into therapy, respectively. After 4 days of metronidazole and 3 days of levofloxacin therapy, the patient became confused, disoriented, with signs of delirium. Since the diagnosis of psychoorganic disorder was made, the therapy with lorazepam and haloperidol was initiated, while metronidazole and levofloxacin were discontinued. Complete recovery 4 days after discontinuation indicates that the patient has experienced antibiotics-induced neurotoxicity. This is the first report of expressed neurotoxicity after the combination of metronidazole and levofloxacin in chronic kidney patients.
31798860	0	13	Metronidazole	Chemical	MESH:D008795
31798860	19	31	levofloxacin	Chemical	MESH:D064704
31798860	40	59	psychotic disorders	Disease	MESH:D011618
31798860	63	85	chronic kidney patient	Disease	MESH:D051436
31798860	137	156	psychotic disorders	Disease	MESH:D011618
31798860	163	176	metronidazole	Chemical	MESH:D008795
31798860	181	193	levofloxacin	Chemical	MESH:D064704
31798860	207	229	chronic kidney patient	Disease	MESH:D051436
31798860	254	267	enterocolitis	Disease	MESH:D004760
31798860	272	289	urinary infection	Disease	MESH:D014552
31798860	459	472	enterocolitis	Disease	MESH:D004760
31798860	477	494	urinary infection	Disease	MESH:D014552
31798860	512	525	metronidazole	Chemical	MESH:D008795
31798860	530	542	levofloxacin	Chemical	MESH:D064704
31798860	603	616	metronidazole	Chemical	MESH:D008795
31798860	631	643	levofloxacin	Chemical	MESH:D064704
31798860	657	664	patient	Species	9606
31798860	709	717	delirium	Disease	MESH:D003693
31798860	742	764	psychoorganic disorder	Disease	MESH:D009358
31798860	792	801	lorazepam	Chemical	MESH:D008140
31798860	806	817	haloperidol	Chemical	MESH:D006220
31798860	839	852	metronidazole	Chemical	MESH:D008795
31798860	857	869	levofloxacin	Chemical	MESH:D064704
31798860	955	962	patient	Species	9606
31798860	999	1012	neurotoxicity	Disease	MESH:D020258
31798860	1052	1065	neurotoxicity	Disease	MESH:D020258
31798860	1091	1104	metronidazole	Chemical	MESH:D008795
31798860	1109	1121	levofloxacin	Chemical	MESH:D064704
31798860	1125	1148	chronic kidney patients	Disease	MESH:D051436
31798860	Negative_Correlation	MESH:D008795	MESH:D004760
31798860	Negative_Correlation	MESH:D064704	MESH:D004760
31798860	Negative_Correlation	MESH:D008140	MESH:D009358
31798860	Negative_Correlation	MESH:D008795	MESH:D014552
31798860	Negative_Correlation	MESH:D064704	MESH:D051436
31798860	Positive_Correlation	MESH:D008795	MESH:D011618
31798860	Positive_Correlation	MESH:D064704	MESH:D011618
31798860	Positive_Correlation	MESH:D064704	MESH:D003693
31798860	Positive_Correlation	MESH:D008795	MESH:D020258
31798860	Negative_Correlation	MESH:D008795	MESH:D051436
31798860	Positive_Correlation	MESH:D008795	MESH:D003693
31798860	Positive_Correlation	MESH:D064704	MESH:D020258
31798860	Negative_Correlation	MESH:D006220	MESH:D003693
31798860	Negative_Correlation	MESH:D008140	MESH:D003693
31798860	Negative_Correlation	MESH:D064704	MESH:D014552
31798860	Comparison	MESH:D008795	MESH:D064704
31798860	Negative_Correlation	MESH:D006220	MESH:D009358

